Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

Item
http://www.wikidata.org/entity/Q37797464
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsApparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center studyReview: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesStandards of care for treatment of recurrent glioblastoma--are we there yet?Statistical and practical considerations for clinical evaluation of predictive biomarkers.Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials.Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience.A specific miRNA signature in the peripheral blood of glioblastoma patients.Personalized medicine in neuro-oncology.Recognizing and correcting failures in glioblastoma treatment.
P2860

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

Item
http://www.wikidata.org/entity/Q37797464
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Should biomarkers be used to d ...... the treatment of glioblastoma?
@en
Should biomarkers be used to d ...... the treatment of glioblastoma?
@nl
type
label
Should biomarkers be used to d ...... the treatment of glioblastoma?
@en
Should biomarkers be used to d ...... the treatment of glioblastoma?
@nl
prefLabel
Should biomarkers be used to d ...... the treatment of glioblastoma?
@en
Should biomarkers be used to d ...... the treatment of glioblastoma?
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Should biomarkers be used to d ...... the treatment of glioblastoma?
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921